Food compounds and DNA methylation: laboratory signals need clinical testing
A review found frequent inhibition of enzymes involved in DNA methylation, but the evidence mainly came from laboratory and animal models.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
The review asked whether compounds derived from food affect enzymes involved in DNA methylation. Most studies reported enzyme inhibition, sometimes depending on concentration or exposure time. These findings support further investigation of a biological mechanism, but they do not demonstrate that eating particular foods or taking these compounds slows aging or prevents disease in people.
The evidence was predominantly preclinical, with varied protocols and doses. The abstract does not establish long-term clinical efficacy, safety or bioavailability, and this summary does not assess the full-text methods.
What the studies measured
Researchers examined food-derived compounds, including curcumin, resveratrol and sulforaphane, for effects on DNA methyltransferase expression and activity. These enzyme measurements address a possible mechanism through which dietary compounds could influence processes relevant to aging.
Why the experimental setting matters
Some studies described interactions between compounds, while others suggested that gut microbes may help mediate their effects. Those observations add biological detail, but they do not establish how a dietary intervention would perform in people.
The original publication
A Systematic Review of Food-Derived DNA Methyltransferase Modulators: Mechanistic Insights and Perspectives for Healthy Aging.
Campisi M, Cannella L, Visioli F et al.
Adv Nutr · 2025
- PubMed ID
- 40975498
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.